These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19961824)

  • 1. Comparing the Southern blot method and polymerase chain reaction product analysis for chimeric RCCX detection in CYP21A2 deficiency.
    Lee HH; Lee YJ; Chao MC
    Anal Biochem; 2010 Apr; 399(2):293-8. PubMed ID: 19961824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the CYP21A2 gene with intergenic recombination and multiple gene deletions in the RCCX module.
    Chang SF; Lee HH
    Genet Test Mol Biomarkers; 2011; 15(1-2):35-42. PubMed ID: 21117955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants of the CYP21A2 and CYP21A1P genes in congenital adrenal hyperplasia.
    Lee HH
    Clin Chim Acta; 2013 Mar; 418():37-44. PubMed ID: 23313747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCR-based detection of the CYP21 deletion and TNXA/TNXB hybrid in the RCCX module.
    Lee HH; Lee YJ; Lin CY
    Genomics; 2004 May; 83(5):944-50. PubMed ID: 15081125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene.
    Fanis P; Skordis N; Phylactou LA; Neocleous V
    Hormones (Athens); 2023 Mar; 22(1):71-77. PubMed ID: 36264454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of the CYP21A2 gene: a 6.2-kb TaqI fragment and a 3.2-kb TaqI fragment mistaken as CYP21A1P.
    Lee HH; Tsai FJ; Lee YJ; Yang YC
    Mol Genet Metab; 2006 Aug; 88(4):372-7. PubMed ID: 16684614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low frequency of the CYP21A2 deletion in ethnic Chinese (Taiwanese) patients with 21-hydroxylase deficiency.
    Lee HH; Lee YJ; Wang YM; Chao HT; Niu DM; Chao MC; Tsai FJ; Lo FS; Lin SJ
    Mol Genet Metab; 2008 Apr; 93(4):450-7. PubMed ID: 18039588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency.
    Coeli FB; Soardi FC; Bernardi RD; de Araújo M; Paulino LC; Lau IF; Petroli RJ; de Lemos-Marini SH; Baptista MT; Guerra-Júnior G; de-Mello MP
    BMC Med Genet; 2010 Jun; 11():104. PubMed ID: 20587039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form.
    Concolino P; Mello E; Minucci A; Giardina E; Zuppi C; Toscano V; Capoluongo E
    BMC Med Genet; 2009 Jul; 10():72. PubMed ID: 19624807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module.
    Lee HH
    Mol Genet Metab; 2005 Jan; 84(1):4-8. PubMed ID: 15639189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudogene
    Lao Q; Zhou K; Parker M; Faucz FR; Merke DP
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prevalence of the Chimeric TNXA/TNXB Gene and Clinical Symptoms of Ehlers-Danlos Syndrome with 21-Hydroxylase Deficiency.
    Gao Y; Lu L; Yu B; Mao J; Wang X; Nie M; Wu X
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32291442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting the association of HLA alleles and haplotypes with CYP21A2 mutations in a large cohort of patients with congenital adrenal hyperplasia.
    Jayakrishnan R; Lao Q; Adams SD; Ward WW; Merke DP
    Gene; 2019 Mar; 687():30-34. PubMed ID: 30419250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the CYP21A1P pseudogene: indication of mutational diversity and CYP21A2-like and duplicated CYP21A2 genes.
    Tsai LP; Cheng CF; Chuang SH; Lee HH
    Anal Biochem; 2011 Jun; 413(2):133-41. PubMed ID: 21324303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare CYP21A2 haplotype clarifies the phenotype-genotype discrepancy in an Italian patient with Non Classical Congenital Adrenal Hyperplasia (NC-CAH).
    Concolino P
    Mol Biol Rep; 2020 Apr; 47(4):3049-3052. PubMed ID: 32185686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia.
    Lao Q; Brookner B; Merke DP
    J Mol Diagn; 2019 Sep; 21(5):924-931. PubMed ID: 31229653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital Adrenal Hyperplasia and Ehlers-Danlos Syndrome.
    Marino R; Moresco A; Perez Garrido N; Ramirez P; Belgorosky A
    Front Endocrinol (Lausanne); 2022; 13():803226. PubMed ID: 35282436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotyping of CYP21A2 for congenital adrenal hyperplasia screening using allele-specific primer extension followed by bead array hybridization.
    Oh Y; Park SW; Chun SM; Lim N; Ahn KS; Ka JO; Jin DK; Han BD
    Mol Diagn Ther; 2009 Dec; 13(6):397-405. PubMed ID: 19925038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia.
    Marino R; Garrido NP; Ramirez P; Notaristéfano G; Moresco A; Touzon MS; Vaiani E; Finkielstain G; Obregón MG; Balbi V; Soria I; Belgorosky A
    J Clin Endocrinol Metab; 2021 Jun; 106(7):e2789-e2802. PubMed ID: 33482002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.